{
  "id": 857033,
  "title": "Citizens reiterates Lyell Immunopharma stock rating on pipeline progress",
  "url": "https://urgent.news/2026/08/14/citizens-reiterates-lyell-immunopharma-stock-rating-on-pipeline",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-14T09:22:52.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/citizens-reiterates-lyell-immunopharma-stock-rating-on-pipeline-progress-93CH-4860098"
  },
  "original_language": "en",
  "account": null,
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Citizens reiterates Immix Biopharma stock rating on pipeline progress",
        "url": "https://urgent.news/2026/08/14/citizens-reiterates-immix-biopharma-stock-rating-on-pipeline-progress",
        "published": "2026-08-14T09:22:46.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}